Is a Transferrin Saturation of 21% Acceptable?
A transferrin saturation of 21% is marginally acceptable in most clinical contexts, sitting just above the critical 20% threshold used to define iron deficiency, but this value warrants clinical correlation with hemoglobin levels, ferritin, and underlying conditions—particularly chronic kidney disease, heart failure, or anemia requiring erythropoiesis-stimulating agents.
Context-Dependent Interpretation
In Chronic Kidney Disease (CKD)
For CKD patients receiving erythropoiesis-stimulating agents (ESAs), a TSAT of 21% is at the lower acceptable limit. Guidelines recommend maintaining TSAT greater than 20% to support optimal erythropoiesis and reduce ESA requirements 1.
Studies demonstrate that maintaining TSAT targets above 20% allows for better hemoglobin correction at lower ESA doses in hemodialysis patients 2. Patients with TSAT just above 20% may still show absent bone marrow iron and could benefit from iron supplementation 2.
Absolute iron deficiency in CKD is defined as TSAT <20% with ferritin <100 ng/mL (predialysis/peritoneal dialysis) or <200 ng/mL (hemodialysis) 3. Your value of 21% technically exceeds this threshold but provides minimal margin.
In General Adult Population
In healthy adults without CKD, a TSAT <16% is typically used to confirm iron deficiency 4. By this standard, 21% would be considered adequate.
However, TSAT values have significant day-to-day and diurnal variation, with concentrations rising in the morning and falling at night 4. A single measurement of 21% could represent functional iron deficiency depending on timing and clinical context.
In Heart Failure
For patients with chronic heart failure, iron deficiency is defined as ferritin <100 μg/L and/or TSAT <20% 3. A TSAT of 21% places you just above the deficiency threshold.
Recent evidence shows that low TSAT (but not ferritin) is independently associated with increased mortality in heart failure patients, with stronger associations in heart failure with preserved ejection fraction 5. Even values slightly above 20% may carry prognostic significance 6.
Clinical Decision Algorithm
Evaluate the following in order:
Check hemoglobin level and ferritin simultaneously 2:
- If hemoglobin is below target AND ferritin <100 ng/mL → Consider iron supplementation despite TSAT of 21%
- If hemoglobin is at target AND ferritin >200 ng/mL → Iron therapy likely not needed
Assess for underlying conditions 1:
- CKD with ESA use: TSAT of 21% may indicate functional iron deficiency requiring IV iron supplementation
- Heart failure: Consider iron supplementation even with TSAT 21% if ferritin <100 ng/mL or clinical symptoms present 3
- Inflammation/infection: TSAT may be falsely low due to inflammatory iron block; check C-reactive protein 1
Consider ESA dose if applicable 2:
- High ESA requirements (≥300 IU/kg/week epoetin or ≥1.5 mg/kg/week darbepoetin) with TSAT 21% suggests functional iron deficiency
- Iron supplementation may reduce ESA requirements even at this TSAT level
Important Caveats
TSAT is not perfectly sensitive or specific for iron deficiency. No single TSAT value accurately discriminates between patients who are or are not functionally iron deficient 1.
The lower the TSAT, the higher the likelihood of iron deficiency, but patients with TSAT >20% can still be functionally iron deficient, particularly in the setting of increased erythropoietic demand 1.
Distinguish functional iron deficiency from inflammatory iron block: Both can present with TSAT <20% and ferritin 100-700 ng/mL. If unclear, a trial of IV iron (50-125 mg weekly for 8-10 doses) can help differentiate—lack of erythropoietic response suggests inflammatory block 1.
In children, TSAT interpretation differs significantly. Values as low as 5% can be seen in iron-replete children, and TSAT <16% alone is insufficient for diagnosing iron deficiency without anemia and low MCV 7, 8.